Delivery Order SPE2DB20D7066-SPE2DB25FC4TM
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $51K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $37,466.05 firm fixed price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of August 1, 2025. This non-set-aside competitive award was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $159,128.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of September 15, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency awarded a $14.76K delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) under a firm fixed-price contract, with an ultimate completion date of September 5, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award involved no set-aside designation,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,248.66 on May 16, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of May 19, 2025, and performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $97,762.11 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30, with a firm fixed price structure and an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) valued at $56,371.98 under a firm fixed price contract type. The award, made on June 26, 2025, with an ultimate completion date of June 27, 2025, represents a non-competitive delivery order utilizing an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.16 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. The order was placed to...
- The Defense Logistics Agency awarded a $37,967.82 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in packages of 30 units. This delivery order, which is a child contract under a larger vehicle, requires completion by September 4, 2025, and was competitively awarded without set-aside provisions. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $26,053.21 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with a completion date of August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $36,245.57 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This competitive, firm fixed-price delivery order was placed under a non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with particular emphasis on...